Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

High Incidence of True Heparin-Induced Thrombocytopenia and Heparin-Induced Thrombocytopenia Antibody Development in Critically Ill Medical Patients

Noppacharn Uaprasert, MB, BCH, Siriporn Jutiamornlerd, MD, Rattaporn Vichitratchaneekorn, Benjaporn Akkawat, BSc, Ponlapat Rojnuckarin, MD PhD, Sunisa Kongkiatkamon, MD

Blood (2017) 130 (Supplement 1): 4646.

https://doi.org/10.1182/blood.V130.Suppl_1.4646.4646

Published: 2017

Journal Articles

Dexrazoxane Does Not Negatively Impact Survival Outcomes in Children and Young Adults with Acute Myeloid Leukemia (AML)

Nathan J. Schloemer, MD, Molly M. Brickler, RN, MSN, CPNP-AC, Vanessa C. McFadden, MD PhD, Yumei Cao, PhD, Raymond G. Hoffmann, PhD, Joseph R. Block, MD, Richard L. Tower, II, MD MS, Michael J. Burke, MD

Blood (2015) 126 (23): 4886.

https://doi.org/10.1182/blood.V126.23.4886.4886

Published: 2015

Journal Articles

Mechanisms and Prevention of Fatal Cardiotoxicity Following High-Dose Cyclophosphamide Therapy

Takuro Nishikawa, MD PhD, Emiko Miyahara, PhD, Koichiro Kurauchi, MD, Erika Watanabe, PhC, Yasuhiro Okamoto, MD, Yoshifumi Kawano, MD PhD

Blood (2014) 124 (21): 5789.

https://doi.org/10.1182/blood.V124.21.5789.5789

Published: 2014

Journal Articles

Uncovering Cardioprotective Strategies For Anthracycline Therapy By Analysis Of Redox and Apoptotic Effects

Daniela E. Egas Bejar, M.D., Joy M. Fulbright, M.D., Fernando F. Corrales-Medina, M.D., Mary E. Irwin, Ph.D., Blake Johnson, M.S., Joya Chandra, Ph.D.

Blood (2013) 122 (21): 1293.

https://doi.org/10.1182/blood.V122.21.1293.1293

Published: 2013

Journal Articles

Dexrazoxane Use in Pediatric Patients with Acute Lymphoblastic or Myeloid Leukemia: Analysis of a National Cohort of Patients in the Pediatric Health Information Systems Database From 1999 to 2009

Dana Sepe, MD, Brian T. Fisher, DO, MSCE, Alix E. Seif, MD, MPH, Yuan-Shung V. Huang, MS, Yimei Li, PhD, Richard Aplenc, MD, PhD

Blood (2011) 118 (21): 4242.

https://doi.org/10.1182/blood.V118.21.4242.4242

Published: 2011

Journal Articles

Vitamin E Does Not Reduce Cardiomyopathy In Doxorubicin treated Rats

Jhon A Guerra, MD, FAAP, Maribel Torres-Serrant, MD, Pedro J Santiago, MD

Blood (2010) 116 (21): 4944.

https://doi.org/10.1182/blood.V116.21.4944.4944

Published: 2010

Journal Articles

The Nucleoside Analogue Acadesine Exerts Antitumoral Activity and Cooperates with Conventional Agents In In Vitro and In Vivo Models of Mantle Cell Lymphoma

Arnau Montraveta, MS, Mercè de Frías, PhD, Clara Campàs, PhD, Elias Campo, MD, PhD, Gael Roue, PhD, Dolors Colomer, PhD

Blood (2010) 116 (21): 3918.

https://doi.org/10.1182/blood.V116.21.3918.3918

Published: 2010

Journal Articles

Biweekly Rituximab, Cyclophosphamide, Vincristine, Non-Pegylated Liposome-Encapsulated Doxorubicin (Myocet®) and Prednisone (R-COMP-14) as Induction Treatment in Poor R-IPI Risk Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL) and Pre-Existing Heart Disease.

Ferdinando Frigeri, MD, Gaetano Corazzelli, MD, Manuela Arcamone, MD, Gaetana Capobianco, MD, Anna Lucania, MD, Cristina Becchimanzi, MD, Gianpaolo Marcacci, MD, Filippo Russo, MD, Maria Rosaria Villa, MD, Lucia Mastrullo, MD, Antonio Pinto, MD

Blood (2009) 114 (22): 1664.

https://doi.org/10.1182/blood.V114.22.1664.1664

Published: 2009

Journal Articles

Transfusional Iron Overload: An Underappreciated Danger in AML Patients?

Jacob Rozmus, MD, FRCPC, Louis D. Wadsworth, MBChB, FRCP, John K. Wu, MBBS, FRCPC

Blood (2009) 114 (22): 4133.

https://doi.org/10.1182/blood.V114.22.4133.4133

Published: 2009

Journal Articles

Erythropoietin Protects Cardiac Myocytes Against Anthracycline-Induced Apoptosis by PI3K-Akt-Mediated Phosphorylation of Glycogen Synthase Kinase-3β.

Murat O. Arcasoy, MD, Ping Fu, MD,PhD

Blood (2006) 108 (11): 1132.

https://doi.org/10.1182/blood.V108.11.1132.1132

Published: 2006

Journal Articles

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

Albert Moghrabi, Donna E. Levy, Barbara Asselin, Ronald Barr, Luis Clavell, Craig Hurwitz, Yvan Samson, Marshall Schorin, Virginia K. Dalton, Steven E. Lipshultz, Donna S. Neuberg, Richard D. Gelber, Harvey J. Cohen, Stephen E. Sallan, Lewis B. Silverman

Blood (2006) 109 (3): 896–904.

https://doi.org/10.1182/blood-2006-06-027714

Published: 2006

Journal Articles

Outcome of Dana-Farber Cancer Institute (DFCI) Consortium Protocol 95–01 for Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL).

Lewis B. Silverman, MD, Donna E. Levy, MS, Virginia K. Dalton, MS, PNP, Steven E. Lipshultz, MD, Richard D. Gelber, PhD, Stephen E. Sallan, MD

Blood (2004) 104 (11): 679.

https://doi.org/10.1182/blood.V104.11.679.679

Published: 2004

NARROW

High Incidence of True Heparin-Induced Thrombocytopenia and Heparin-Induced Thrombocytopenia Antibody Development in Critically Ill Medical Patients

Dexrazoxane Does Not Negatively Impact Survival Outcomes in Children and Young Adults with Acute Myeloid Leukemia (AML)

Mechanisms and Prevention of Fatal Cardiotoxicity Following High-Dose Cyclophosphamide Therapy

Uncovering Cardioprotective Strategies For Anthracycline Therapy By Analysis Of Redox and Apoptotic Effects

Dexrazoxane Use in Pediatric Patients with Acute Lymphoblastic or Myeloid Leukemia: Analysis of a National Cohort of Patients in the Pediatric Health Information Systems Database From 1999 to 2009

Vitamin E Does Not Reduce Cardiomyopathy In Doxorubicin treated Rats

The Nucleoside Analogue Acadesine Exerts Antitumoral Activity and Cooperates with Conventional Agents In In Vitro and In Vivo Models of Mantle Cell Lymphoma

Biweekly Rituximab, Cyclophosphamide, Vincristine, Non-Pegylated Liposome-Encapsulated Doxorubicin (Myocet®) and Prednisone (R-COMP-14) as Induction Treatment in Poor R-IPI Risk Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL) and Pre-Existing Heart Disease.

Transfusional Iron Overload: An Underappreciated Danger in AML Patients?

Erythropoietin Protects Cardiac Myocytes Against Anthracycline-Induced Apoptosis by PI3K-Akt-Mediated Phosphorylation of Glycogen Synthase Kinase-3β.

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

Outcome of Dana-Farber Cancer Institute (DFCI) Consortium Protocol 95–01 for Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only